Drugs that contain Prednisone

1. List of Rayos drug patents

RAYOS's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8309124 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 27 days from now)

US8394407 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 27 days from now)

US9040085 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 27 days from now)

US9186332 HORIZON Delayed release tablet with defined core geometry
Apr, 2024

(1 year, 27 days from now)

US9504699 HORIZON Delayed-release glucocorticoid treatment of rheumatoid disease
Aug, 2027

(4 years from now)

US8168218 HORIZON Delayed release tablet with defined core geometry
Jan, 2028

(4 years from now)

Market Authorisation Date: 26 July, 2012

Treatment: Treatment of diseases or conditions by the use of a delayed release 1, 2, or 5 mg prednisone tablet; Treatment of diseases or conditions by the use of a delayed-release 1,2, or 5mg prednisone tablet; ...

Dosage: TABLET, DELAYED RELEASE;ORAL

How can I launch a generic of RAYOS before it's patent expiration?
More Information on Dosage

RAYOS family patents

14

United States

3

Slovenia

3

China

3

European Union

2

Israel

2

South Africa

2

Denmark

2

Mexico

2

Australia

2

Singapore

2

Brazil

2

Portugal

2

Cyprus

2

Spain

2

Korea, Republic of

2

Poland

2

Japan

2

Canada

IB

1

IB

1

Austria

1

Hong Kong

1

Russia

1

Morocco

1

Norway

1

Croatia

1

Malaysia

1

RS

1

United Kingdom

1

Ukraine

EA

1

EA

1

Tunisia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in